Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Development of a nationwide genomic screening network for lung cancer with rare driver oncogenes and investigation of the mechanism of drug resistance

Date

08 Oct 2016

Session

Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Presenters

Shingo Matsumoto

Authors

S. Matsumoto

Author affiliations

Department Of Thoracic Oncology, National Cancer Center Hospital East, 277-8577 - Kashiwa/JP

More

Resources

Reserved to ESMO members

Login Join ESMO

Watch the webcast View the presentation

Resources from the same session

08 Oct 2016

Treatment decisions at ALK TKI resistance

Presenter: Maurice Perol

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast

08 Oct 2016

Introduction

Presenter: Yuichiro Ohe

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast

08 Oct 2016

Conclusions and clinical perspectives

Presenter: Solange Peters

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast